Drug intelligence / Profile preview

influenza vaccine + respiratory syncytial virus vaccine (ISR Vaccine AB)

Development stage
Preclinical
Lead developer
ISR Vaccine
Modality
Vaccines & Immunotherapeutics
Administration
Intranasal, Inhalation
01

Overview

The influenza and respiratory syncytial virus (RSV) combination vaccine is an inhalable mucosal vaccine candidate under development by ISR Vaccine AB, with participation from Icosagen. Designed for intranasal or inhalable administration, the vaccine aims to elicit mucosal immune responses in the respiratory tract, providing a first line of defense against infection by both influenza and RSV. This approach is intended to offer a needle-free alternative to traditional vaccines while potentially providing superior protection against viral transmission by targeting the site of entry.

Other names
Nasal vaccine (influenza/RSV)inhalable vaccinemucosal vaccine
02

Targets

Flu (Influenza surface proteins)

Beyond the preview

Go deeper on influenza vaccine + respiratory syncytial virus vaccine (ISR Vaccine AB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on influenza vaccine + respiratory syncytial virus vaccine (ISR Vaccine AB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call